PROSIDION LIMITED SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENTScientific Advisory Board and Consulting Agreement • February 27th, 2009 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • England and Wales
This Scientific Advisory Board and Consulting Agreement (this “Agreement”) is made and entered into as of December 16, 2008, and effective as of January 1, 2009 (the “Effective Date”), by and between Prosidion Limited, a company registered in England and Wales under registered number 4600121 with its registered office at Watlington Road, Oxford, UK OX4 6LT (the “Company”) and Dr. Daryl Granner, Professor, an individual with an address of 707 Light Hall, Vanderbilt University Medical Centre, Nashville, Tennessee 37232, USA (“Consultant ”).
NanoViricides, Inc. SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENTScientific Advisory Board and Consulting Agreement • November 14th, 2006 • Nanoviricides, Inc.
THIS SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENT (the “Agreement”), made this day of ("the Effective Date"), is entered into by Nanoviricide, Inc., a Florida corporation with its principal place of business at 135 Wood Street, West Haven, CT 06516 (the “Company”), and (the “Consultant”).
